Change search criteria ↓

Search results

1 530 projects found matching your search criteria:

  1. 1. NADPH oxidase genes expression in peripheral blood mononuclear cells (PBMC) in anti-TNF alpha-treated rheumatoid arthrit…

    Principal investigator: Tomasz Stanisław Wysocki

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

    Call: PRELUDIUM 16, Panel: NZ5

  2. 2. Changes in lipid metabolism of resistant to BRAF/MEK inhibitors human melanoma cells associated with the presence of adi…

    Principal investigator: dr Aleksandra Simiczyjew

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: SONATA 16, Panel: NZ5

  3. 3. Impact of personality disorders on adherence to psychiatric treatment

    Principal investigator: Maja Biała

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski Kształcenia Podyplomowego

    Call: PRELUDIUM 1, Panel: NZ5

  4. 4. Developing an AI algorithm for longitudinal tracking of post-treatment changes in brain metastases using a hybrid Uncert…

    Principal investigator: Monika Żaneta Pytlarz

    Sano - Centrum Zindywidualizowanej Medycyny Obliczeniowej - Międzynarodowa Fundacja Badawcza

    Call: PRELUDIUM 24, Panel: NZ7

  5. 5. Artificial intelligence in predicting treatment outcomes of abdominal cancers – implementation of machine learning and d…

    Principal investigator: dr Krzysztof Bartnik

    Politechnika Warszawska

    Call: SONATINA 9, Panel: NZ7

  6. 6. Bifunctional, pH-responsive zeolite-bisphosphonates complex as a base for the production of smart bone implant for osteo…

    Principal investigator: prof. Agata Natalia Przekora-Kuśmierz

    Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

    Call: OPUS 22, Panel: NZ7

  7. 7. Organizational barriers to acute stroke care in the Pomeranian Voivodeship: A mixed-methods study.

    Principal investigator: Krzysztof Bartosz Klimiuk

    Gdański Uniwersytet Medyczny

    Call: PRELUDIUM 24, Panel: NZ7

  8. 8. Multidimensional analysis of the gut microbiome, including the virome,archaeome, bacteriome, and mycobiome,along with ge…

    Principal investigator: dr Agnieszka Aleksandra Krawczyk

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ4

  9. 9. Electrospinning as an effective approach to topical delivery of natural compounds with wound healing potential

    Principal investigator: Anna Gościniak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 23, Panel: NZ7

  10. 10. Application of integrated transcriptomics as a tool for early diagnosis, prognosis and treatment monitoring in patients …

    Principal investigator: Joanna Anna Jarosz-Popek

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 22, Panel: NZ6

  11. 11. Innovative hybrid materials useful in the syntheis of dressings for the treatment of diabetic foot ulcers

    Principal investigator: dr hab. Beata Kolesińska

    Politechnika Łódzka, Wydział Chemiczny

    Call: OPUS 16, Panel: ST8

  12. 12. Analysis of relationsips between T cell exhaustion, genetic heterogeneity of hepatitis C virus (HCV) epitopes recognized…

    Principal investigator: dr hab. Kamila Caraballo Cortés

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 10, Panel: NZ6

  13. 13. Treatment agreement as a source of medical law

    Principal investigator: dr Grzegorz Paweł Glanowski

    Uniwersytet Jagielloński, Wydział Prawa i Administracji

    Call: PRELUDIUM 8, Panel: HS5

  14. 14. Evaluation of the molecular basis of beta-hydroxy-beta-methylbutyrate as a tool to support the medical treatment of musc…

    Principal investigator: dr hab. Tomasz Sadkowski

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

    Call: OPUS 19, Panel: NZ5

  15. 15. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

    Call: SONATA BIS 14, Panel: NZ5

  16. 16. Modulation of protein interaction networks as a new therapeutic target in the treatment of hereditary retinal dystrophie…

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: SONATA 19, Panel: NZ5

  17. 17. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden…

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

    Call: PRELUDIUM 22, Panel: NZ5

  18. 18. The impact of probiotic supplementation on outcomes of surgical treatment of obesity: exploring the interplay between gu…

    Principal investigator: Marta Potrykus

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ5

  19. 19. Does myoinositol trispyrophosphate protect against the developement of the right ventricular heart failure in pulmonary …

    Principal investigator: Zuzanna Gabriela Zambrowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: PRELUDIUM 21, Panel: NZ5

  20. 20. Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved …

    Principal investigator: dr hab. Urszula Mackiewicz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: OPUS 23, Panel: NZ5

  21. 21. Liposomal nanoformulations of cannabidiol with celecoxib or 2,5-dimethylcelecoxib as a novel treatment option for gliobl…

    Principal investigator: dr hab. Violetta Katarzyna Krajka-Kuźniak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 3, Panel: NZ5

  22. 22. Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell the…

    Principal investigator: prof. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

    Call: PRELUDIUM BIS 3, Panel: NZ5

  23. 23. The role of NPM1 as biomarker of the targeted therapy efficacy in chronic lymphocytic leukemia patients

    Principal investigator: prof. Krzysztof Georgios Giannopoulos

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

    Call: PRELUDIUM BIS 3, Panel: NZ5

  24. 24. New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica…

    Principal investigator: prof. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

    Call: OPUS 22, Panel: NZ5

  25. 25. Susceptibility of uterine leiomyomas to hormonal treatment depending on the genetic subtype

    Principal investigator: Gabriela Milewska

    Uniwersytet Medyczny w Białymstoku

    Call: PRELUDIUM 20, Panel: NZ5

  26. 26. The genome-wide DNA methylation pattern alterations in the peripheral whole blood cells' in Graves' disease patients and…

    Principal investigator: Mikołaj Artur Radziszewski

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 20, Panel: NZ5

  27. 27. Verification of personalized therapeutic strategy based on Integrated Stress Response inhibition for myeloid neoplasms w…

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 21, Panel: NZ5

  28. 28. Iron chelators as tyrosine kinase inhibitors - a new strategy for the treatment of glioblastoma multiforme

    Principal investigator: dr hab. Anna Dominika Mrozek-Wilczkiewicz

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

    Call: PRELUDIUM BIS 2, Panel: NZ5

  29. 29. New insights into multifaceted targeted therapy for treatment of glioblastoma multiforme.

    Principal investigator: dr Katarzyna Anna Malarz

    UNIWERSYTET ŚLĄSKI, Wydział Nauk Ścisłych i Technicznych

    Call: OPUS 18, Panel: NZ5

  30. 30. Testing of cation carrier derivatives as prospective therapeutic agents for the treatment of B-cell-derived malignancies…

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 18, Panel: NZ5

  31. 31. Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability…

    Principal investigator: Marta Anna Małkiewicz

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

    Call: PRELUDIUM 17, Panel: NZ5

  32. 32. Liposomal berberine and anti-CD47 antibody as an effective therapy for the treatment of colorectal cancer

    Principal investigator: dr Martyna Maria Mianowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: PRELUDIUM 17, Panel: NZ5

  33. 33. Nowel polymeric nanoparticles for pulmonary nucleic acid therapy - synthesis, toxicological analysis and biological/ther…

    Principal investigator: prof. Maria Jolanta Bryszewska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: BEETHOVEN LIFE 1, Panel: NZ5

  34. 34. Potential clinical application of DNA methylation in early diagnosis and treatment of rheumatoid arthritis patients

    Principal investigator: dr Marzena Ciechomska

    Instytut Reumatologii im. prof. dr hab. med. Eleonory Reicher

    Call: SONATA BIS 8, Panel: NZ5

  35. 35. Metagenomics and metabolomics-based microbiome profiles to identify distal gut disbiosis correlating with cancer therapy…

    Principal investigator: prof. Jerzy Zygmunt Ostrowski

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: OPUS 14, Panel: NZ5

  36. 36. Longitudinal assessment of changes in the psychosocial functioning of patients with adolescent idiopathic scoliosis befo…

    Principal investigator: dr hab. Ewa Misterska

    Wyższa Szkoła Bezpieczeństwa w Poznaniu

    Call: OPUS 14, Panel: NZ5

  37. 37. Molecular mechanism of action and therapeutic effect of 5-aza-2'-deoxycytidine and topoisomerase inhibitors combination …

    Principal investigator: dr hab. Wojciech Kałas

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 13, Panel: NZ5

  38. 38. Photoimmunotherapy - novel therapeutic strategy for glioblastoma.

    Principal investigator: dr hab. Gabriela Krämer-Marek

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii

    Call: OPUS 13, Panel: NZ5

  39. 39. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

    Principal investigator: prof. Adam Janusz Dziki

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 12, Panel: NZ5

  40. 40. Role of adipose tissue hormones in pathogenesis and treatment of cryptoglandular anal fistula

    Principal investigator: Marcin Krzysztof Włodarczyk

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 12, Panel: NZ5

  41. 41. Association of selected, inherited genetic factors with the effectiveness of treatment in head and neck squamous cell ca…

    Principal investigator: dr hab. Dorota Monika Butkiewicz

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: OPUS 12, Panel: NZ5

  42. 42. Modulation of fatty acid binding protein 4 and dietary fatty acid intake as a potential therapeutic target in the manage…

    Principal investigator: Paula Mosińska

    Uniwersytet Medyczny w Łodzi, Wydzial Lekarski

    Call: PRELUDIUM 11, Panel: NZ5

  43. 43. Novel pro-oxidative strategies in the treatment of B cell acute lymphoblastic leukemia

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA BIS 5, Panel: NZ5

  44. 44. Evaluation of the effectiveness of the low FODMAP diet in the treatment of functional abdominal pain in children.

    Principal investigator: Katarzyna Mirosława Boradyn

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Nauki o Żywności

    Call: PRELUDIUM 9, Panel: NZ5

  45. 45. Oxidation products of 5-methylcytosine as a new predictive markers for respons to systemic chemotherapy of breast cancer…

    Principal investigator: dr hab. Marek Foksiński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 9, Panel: NZ5

  46. 46. Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients…

    Principal investigator: dr hab. Ewa Lech-Marańda

    Instytut Hematologii i Transfuzjologii

    Call: OPUS 7, Panel: NZ5

  47. 47. Cancer stem cells signaling pathways as a therapeutic terget in ovarian cancer chemotherapy

    Principal investigator: prof. Maciej Zabel

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: OPUS 7, Panel: NZ5

  48. 48. Study of the role of follicle stimulating hormone and its receptor in growth and putative treatment strategies for prost…

    Principal investigator: Joanna Stelmaszewska

    Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

    Call: PRELUDIUM 6, Panel: NZ5

  49. 49. Analysis of changes in gene expression and regulatory mechanisms in the tissue of neuropathic ulcers in patients with ty…

    Principal investigator: prof. Maciej Tadeusz Małecki

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 6, Panel: NZ5

  50. 50. The use of medical laser and stem cells in the treatment of end stage coronary artery disease

    Principal investigator: dr hab. Jerzy Stanisław Sadowski

    Krakowski Szpital Specjalistyczny im. Jana Pawła II

    Call: OPUS 2, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski